ZA200902354B - Crystalline forms of thiazolidinedione compound and its manufacturing method - Google Patents

Crystalline forms of thiazolidinedione compound and its manufacturing method

Info

Publication number
ZA200902354B
ZA200902354B ZA200902354A ZA200902354A ZA200902354B ZA 200902354 B ZA200902354 B ZA 200902354B ZA 200902354 A ZA200902354 A ZA 200902354A ZA 200902354 A ZA200902354 A ZA 200902354A ZA 200902354 B ZA200902354 B ZA 200902354B
Authority
ZA
South Africa
Prior art keywords
manufacturing
crystalline forms
thiazolidinedione compound
thiazolidinedione
compound
Prior art date
Application number
ZA200902354A
Other languages
English (en)
Inventor
Hisaki Kajino
Yutaka Ikeuchi
Hiroshi Miyamoto
Satoru Nihei
Eiji Numagami
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of ZA200902354B publication Critical patent/ZA200902354B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200902354A 2007-02-08 2009-04-03 Crystalline forms of thiazolidinedione compound and its manufacturing method ZA200902354B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90025107P 2007-02-08 2007-02-08

Publications (1)

Publication Number Publication Date
ZA200902354B true ZA200902354B (en) 2010-03-31

Family

ID=39521789

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200902354A ZA200902354B (en) 2007-02-08 2009-04-03 Crystalline forms of thiazolidinedione compound and its manufacturing method

Country Status (18)

Country Link
US (2) US8236834B2 (es)
EP (1) EP2086971A1 (es)
JP (1) JP5748954B2 (es)
KR (1) KR20090107013A (es)
CN (1) CN101578283B (es)
AR (1) AR065272A1 (es)
AU (1) AU2008215384B2 (es)
BR (1) BRPI0805830A2 (es)
CA (2) CA2665048C (es)
IL (1) IL197825A0 (es)
MX (1) MX2009003535A (es)
NZ (1) NZ575786A (es)
PE (1) PE20090647A1 (es)
RU (1) RU2414470C2 (es)
SG (1) SG193039A1 (es)
TW (2) TW201336497A (es)
WO (1) WO2008099944A1 (es)
ZA (1) ZA200902354B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
EP2311834A4 (en) * 2008-07-31 2011-11-02 Daiichi Sankyo Co Ltd CRYSTAL OF A THIAZOLIDINE CONNECTION AND METHOD FOR THE PRODUCTION THEREOF
TW201008935A (en) * 2008-07-31 2010-03-01 Daiichi Sankyo Co Ltd Crystalline forms of thiazolidinedione compound and its manufacturing method
US8420819B2 (en) * 2009-06-03 2013-04-16 Boehringer Ingelheim International Gmbh Process for optimizing the particle size of an active pharmaceutical ingredient by crystallization
WO2011065420A1 (ja) 2009-11-26 2011-06-03 第一三共株式会社 ６－置換－１－メチル－１ｈ－ベンズイミダゾール誘導体の製造法及びその製造中間体
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013068486A1 (en) 2011-11-08 2013-05-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of male infertility
CA2941562C (en) 2013-03-14 2021-09-21 Deuterx, Llc Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
WO2015109037A1 (en) 2014-01-15 2015-07-23 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135537A (en) * 1997-10-08 2006-08-20 Daiichi Sankyo Co Ltd Melted heterocyclic compounds
JP3488099B2 (ja) * 1997-10-08 2004-01-19 三共株式会社 置換縮合複素環化合物
JP4169450B2 (ja) * 1999-04-07 2008-10-22 第一三共株式会社 インスリン抵抗性改善剤
KR100588284B1 (ko) 1999-04-07 2006-06-09 상꾜 가부시키가이샤 아민 유도체 화합물
WO2000064893A2 (en) * 1999-04-23 2000-11-02 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic
EP1277745A4 (en) 2000-04-25 2004-09-15 Kyorin Seiyaku Kk NEW STABLE CRYSTALS OF THIAZOLIDINDION DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
AU2002354460A1 (en) * 2001-12-11 2003-07-09 Sankyo Company, Limited Medicinal composition
JP5249484B2 (ja) * 2001-12-11 2013-07-31 第一三共株式会社 医薬組成物
JP2004083574A (ja) 2002-06-25 2004-03-18 Sankyo Co Ltd 利尿剤及びペルオキシソーム増殖因子活性化受容体（ＰＰＡＲ）γ活性化剤を含有する医薬組成物
AU2003246187A1 (en) * 2002-06-25 2004-01-06 Sankyo Company, Limited MEDICINAL COMPOSITION CONTAINING DIURETIC AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) Gamma ACTIAVTOR
JP2004075448A (ja) 2002-08-15 2004-03-11 Taiyo Yuden Co Ltd 圧電磁器組成物、圧電磁器組成物の製造方法および圧電セラミック部品
TW200505834A (en) 2003-03-18 2005-02-16 Sankyo Co Sulfamide derivative and the pharmaceutical composition thereof
JP2005162727A (ja) * 2003-03-18 2005-06-23 Sankyo Co Ltd スルファミド誘導体及びその医薬組成物
KR101150739B1 (ko) 2004-09-28 2012-06-08 상꾜 가부시키가이샤 6-치환-1-메틸-1-ｈ-벤즈이미다졸 유도체의 제조 방법 및 그 제조 중간체
JP4789180B2 (ja) * 2004-09-28 2011-10-12 第一三共株式会社 ６−置換−１−メチル−１−ｈ−ベンズイミダゾール誘導体の製造方法及びその製造中間体
CN101415422B (zh) * 2006-02-09 2012-11-07 第一三共株式会社 抗癌药用组合物
TW201008935A (en) 2008-07-31 2010-03-01 Daiichi Sankyo Co Ltd Crystalline forms of thiazolidinedione compound and its manufacturing method
EP2311834A4 (en) 2008-07-31 2011-11-02 Daiichi Sankyo Co Ltd CRYSTAL OF A THIAZOLIDINE CONNECTION AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
AU2008215384B2 (en) 2011-06-23
CN101578283A (zh) 2009-11-11
CA2728541C (en) 2013-04-02
CA2665048C (en) 2011-11-08
EP2086971A1 (en) 2009-08-12
US20120252854A1 (en) 2012-10-04
KR20090107013A (ko) 2009-10-12
RU2414470C2 (ru) 2011-03-20
JP2010517932A (ja) 2010-05-27
SG193039A1 (en) 2013-09-30
US20110046388A1 (en) 2011-02-24
IL197825A0 (en) 2009-12-24
NZ575786A (en) 2011-05-27
AU2008215384A8 (en) 2009-06-11
US8552038B2 (en) 2013-10-08
RU2009115179A (ru) 2010-10-27
CN101578283B (zh) 2013-01-02
US20110213158A9 (en) 2011-09-01
WO2008099944A1 (en) 2008-08-21
MX2009003535A (es) 2009-05-11
JP5748954B2 (ja) 2015-07-15
AR065272A1 (es) 2009-05-27
AU2008215384A1 (en) 2008-08-21
US8236834B2 (en) 2012-08-07
TW201336497A (zh) 2013-09-16
BRPI0805830A2 (pt) 2011-08-30
CA2665048A1 (en) 2008-08-21
CA2728541A1 (en) 2008-08-21
TW200838512A (en) 2008-10-01
PE20090647A1 (es) 2009-05-29

Similar Documents

Publication Publication Date Title
ZA200902354B (en) Crystalline forms of thiazolidinedione compound and its manufacturing method
IL232511B (en) A method for the production of a sulfonyl-amide compound and intermediate compounds
TWI365508B (en) Manufacturing method of semiconductor device
HK1200440A1 (zh) 種抑制劑的結晶形式
EP2357091A4 (en) EXTERNAL PART AND MANUFACTURING METHOD THEREFOR
TWI319212B (en) Method of chip manufacturing
GB0605360D0 (en) Method of manufacture
TWI372586B (en) Capacitor-embedded substrate and method of manufacturing the same
IL198266A0 (en) Crystalline modification of fipronil
HK1131696A1 (en) Semiconductor component and method of manufacture
HK1125739A1 (en) Semiconductor component and method of manufacture
IL198262A0 (en) Crystalline modification of fipronil
IL198264A0 (en) Crystalline modification of fipronil
EP2341092A4 (en) EPOXY COMPOUND AND METHOD OF MANUFACTURING THEREOF
GB0702402D0 (en) Method of creating crystalline substances
ZA200909147B (en) IM-16 crystallized solid and method of preparation thereof
GB0610468D0 (en) A method of manufacturing a component
IL198265A0 (en) Crystalline modification of fipronil
GB2456096B (en) Crystalline form of benzothiophene compound and process for preparation thereof
HK1124432A1 (en) Semiconductor component and method of manufacture
GB0720958D0 (en) Method of manufacturing an article
EP2197859A4 (en) PROCESS FOR PRODUCING BENZOXAZINONE-BASED COMPOUND
EP2171746A4 (en) PROCESS FOR PREPARING A CRYSTALLINE SEMICONDUCTOR THIN LAYER
EP2103594A4 (en) METHOD FOR PRODUCING AN NITROGEN-CONTAINING COMPOUND
GB0710680D0 (en) Novel crystalline form of olmesartan medoxmil